This is a demo store. No orders will be fulfilled.

Tafasitamab (anti-CD19) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to CD19, >95%, high purity, Human IgG1, Antibody of CD19, Antibody of CD19

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human,Rhesus monkey
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab170635
Grouped product items
SKU Size
Availability
Price Qty
Ab170635-100μg
100μg
10
$89.90
Ab170635-1mg
1mg
4
$449.90
Ab170635-5mg
5mg
1
$1,299.90
Ab170635-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,949.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Tafasitamab (anti-CD19) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to CD19, >95%, high purity, Human IgG1, Antibody of CD19
Synonyms B-lymphocyte surface antigen B4 | Differentiation antigen CD19 | T-cell surface antigen Leu-12
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity CD19
Application ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Recombinant, Validated
Action Type BINDING AGENT
Mechanism of action Antibody of CD19
Product Description

Tafasitamab (anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19.
Purity>95% (SDS-PAGE&SEC)
Endotoxin Level< 0.01EU/μg

Product Properties

Antibody Type Primary antibody
Clonality Recombinant
Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 27.0 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 180.8 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Source CHO supernatant
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 1422527-84-1

Associated Targets(Human)

CD19 Tclin B-lymphocyte antigen CD19 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Tafasitamab (anti-CD19) (Ab170635) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD19 (red) with Tafasitamab (anti-CD19) (Ab170635). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Tafasitamab (anti-CD19) (Ab170635) - SEC
The purity of Tafasitamab (anti-CD19) (Ab170635) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0303039 Certificate of Analysis Mar 08, 2024 Ab170635
ZJ24F0303038 Certificate of Analysis Mar 08, 2024 Ab170635
ZJ24F0303037 Certificate of Analysis Mar 08, 2024 Ab170635

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.